Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Interest & Investment Income: 2017-2021

Historic Interest & Investment Income for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Dec 2021 value amounting to $97,000.

  • Kiniksa Pharmaceuticals International's Interest & Investment Income rose 6340.00% to $322,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $536,000, marking a year-over-year change of. This contributed to the annual value of $97,000 for FY2021, which is 91.45% down from last year.
  • As of FY2021, Kiniksa Pharmaceuticals International's Interest & Investment Income stood at $97,000, which was down 91.45% from $1.1 million recorded in FY2020.
  • Kiniksa Pharmaceuticals International's Interest & Investment Income's 5-year high stood at $6.0 million during FY2019, with a 5-year trough of $97,000 in FY2021.
  • For the 3-year period, Kiniksa Pharmaceuticals International's Interest & Investment Income averaged around $2.4 million, with its median value being $1.1 million (2020).
  • In the last 5 years, Kiniksa Pharmaceuticals International's Interest & Investment Income soared by 792.06% in 2018 and then crashed by 91.45% in 2021.
  • Kiniksa Pharmaceuticals International's Interest & Investment Income (Yearly) stood at $529,000 in 2017, then surged by 792.06% to $4.7 million in 2018, then increased by 28.18% to $6.0 million in 2019, then crashed by 81.25% to $1.1 million in 2020, then plummeted by 91.45% to $97,000 in 2021.